- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Kilitch Drugs (India) Limited — Board Meeting, 13-08-2026: Outcome of Board Meeting
13-08-2026 | 08:56 pm
13-08-2026 | 08:56 pm
Kilitch Drugs' board approved Q1 financial results. Consolidated Net Sales stood at ₹44.88 Cr, with Profit After Tax at ₹1.97 Cr. Basic EPS for the quarter was ₹0.83.
No comments yet. Be the first to comment!